Tony Hunter, Brian Druker and John Mendelsohn have won this year’s Tang Prize in biopharmaceutical science for their breakthroughs in developing targeted cancer therapies, the Tang Prize Selection Committee announced yesterday.
Their research and findings of protein tyrosine phosphorylation and tyrosine kinases as oncogenes have led to successful targeted cancer therapies, the committee said.
The three winners, all Americans, have shown how basic science can lead to clinical applications that benefit humankind, said Chang Wen-chang (張文昌), a member of Academia Sinica and the convener of the selection committee.
Photo: CNA
Hunter demonstrated that a mechanism called tyrosine phosphorylation acts as a master on/off switch for a number of key proteins that are critical for successful cancer therapies, the committee said.
Hunter, a professor of biology at the Salk Institute, gave birth to the field of targeted therapies after discovering in 1979 the mechanism of tyrosine phosphorylation and that the oncogene Src is a tyrosine kinase.
The historic discovery paved the way for active research in the following two decades on tyrosine kinase oncogenes, ultimately leading to the development of tyrosine kinase inhibitors (TKIs).
Based on Hunter’s discovery, Druker, the director of Oregon Health & Science University’s Knight Cancer Institute, led the successful clinical trial of a cancer-fighting drug called imatinib.
The drug turned chronic myelogenous leukemia, a cancer that once had a very low survival rate, into a manageable condition.
Gleevec, a brand of imatinib, shuts off oncogenic signals by inhibiting Abl-protein tyrosine kinases as predicted by Hunter’s original research, the committee said.
Gleevec has also been successfully used in the treatment of acute lymphocytic leukemia and certain types of gastrointestinal stromal tumors by inhibiting other tyrosine kinase oncoproteins.
There are more than 26 TKIs that have been approved for clinical use. All of the discoveries have Druker’s first successful trials to thank because they spurred this still burgeoning targeted therapy era, the committee said.
John Mendelsohn, president emeritus of MD Anderson Cancer Center, took another approach to combating cancer.
An alternative way of shutting off the activities of tyrosine kinases on the cell surface (receptor tyrosine kinase) is to develop antibodies against the extracellular domain of the receptor, the committee said.
In such a way, the natural ligand, or growth factor, can no longer bind and the receptor tyrosine kinase is no longer activated. Mendelsohn and his team came up with the idea that antibodies targeting the epidermal growth factor receptor (EGFR) may be an effective strategy for cancer treatment.
Mendelsohn led his team in conducting preclinical research and proceeded to develop the anti-EGFR antibody cetuximab, which eventually won the US Food and Drug Administration’s approval for the treatment of colon cancer and head/neck cancer.
‘LONE WOLF’: The suspect was difficult to locate, as he did not use a cellphone, did not contact family and often lived in abandoned sites or parks, police said Taipei police on Thursday morning arrested a man accused of numerous burglaries and at least 14 incidents of sexual assault spanning more than 20 years, in what might be the nation’s most notorious crime spree in recent years. Sixty-year-old Tu Ming-lang (涂明朗) — who was yesterday placed in judicial detention, after a judge determined he was a flight risk without a fixed address — faces multiple charges of sexual assault and burglary, police said. A task force comprised of various law enforcement agencies arrested Tu as part of an investigation into an April 28 burglary in Daan District (大安), in which a
Ninth graders were asked to define “trolling” on this year’s standardized exam, reflecting efforts to make the test better reflect real-life situations. Adjustments to this year’s Comprehensive Assessment Program for Junior High School Students were revealed on Sunday, after the last cohort of students completed the test over the weekend. The Ministry of Education solicited feedback about the test from teachers, who approved of the new question in the English portion. Not only was question No. 20 “very much in line with real-life situations,” but it also used a new style in which students were asked to ascertain the correct dictionary definition based
Taiwan is on alert for monkeypox, a rare viral disease that has caused 87 infections in 11 countries over the past three weeks, the Centers for Disease Control (CDC) said on Saturday. The WHO on Friday convened an emergency session to discuss a sudden outbreak of monkeypox in North America and Europe. Since the beginning of this month, 87 confirmed cases and 28 possible cases have been identified in 11 countries. The countries with the highest case counts are England with 29 cases, and Portugal and Spain with 23 each. Monkeypox is a viral zoonotic disease occurring primarily in the tropical rainforest areas
ADAPTING: The CECC said the policy change would happen this week at the earliest, while PCR testing stations would be used to diagnose people and prescribe drugs The general public would be able to use a positive rapid test result that has been confirmed by a doctor for COVID-19 diagnosis starting later this week at the soonest, the Central Epidemic Command Center (CECC) said yesterday, as it reported 79,441 new local infections and 53 deaths. The center on Saturday announced that it was expanding the rapid test diagnosis policy to people living in indigenous townships and outlying islands, starting today. Minister of Health and Welfare Chen Shih-chung (陳時中), who heads the center, yesterday said the policy might be further expanded to include “all people” this week, at the soonest. He
RSS